Verzögert Sao Paulo Andere Börsenplätze | % 5 Tage | % 1. Jan. | ||
268,3 BRL | -1,79% | +0,29% | -2,56% |
16.05. | Laboratory Corp Of America Holdings Insider verkaufte Aktien im Wert von $421.655, laut einer aktuellen SEC Einreichung | MT |
16.05. | LABORATORY CORPORATION OF AMERICA HOLDINGS : Baird behält seine Kaufempfehlung bei | ZM |
Kurzporträt
Laboratory Corporation of America Holdings ist das zweitgrößte klinische Labor in den Vereinigten Staaten. Der Nettoumsatz (einschließlich konzerninterner Umsätze) gliedert sich wie folgt nach Tätigkeitsbereichen:
- Klinische Labordienstleistungen (63,9%): Routinetests, Patientendiagnosen, Krankheitsüberwachung und -behandlung sowie andere Dienstleistungen;
- Entwicklung und klinische Studien (36,1%): für Pharma-, Biotechnologie-, Medizintechnik- und Diagnostikunternehmen.
Der Nettoumsatz verteilt sich geographisch wie folgt: Nordamerika (81,2%), Europa (12,7%) und Sonstige (6,1%).
Mitarbeiterzahl: 61 975
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Diagnostics Laboratories 77,4% | 9 204 | 61,9% | 9 415 | 77,4% | +2,30% |
Biopharma Laboratory Services 22,8% | 5 710 | 38,4% | 2 774 | 22,8% | -51,42% |
Intercompany Eliminations and Other -0,2% | -37 | -0,2% | -28 | -0,2% | -24,93% |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States 83,7% | 11 531 | 77,5% | 10 178 | 83,7% | -11,73% |
9,0% | 1 934 | 13,0% | 1 095 | 9,0% | -43,40% |
Other 4,0% | 1 041 | 7,0% | 486 | 4,0% | -53,29% |
North America 3,3% | 371 | 2,5% | 403 | 3,3% | +8,61% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Adam Schechter CEO | Chief Executive Officer | 58 | 01.04.13 |
Glenn Eisenberg DFI | Director of Finance/CFO | 63 | 16.06.14 |
Sandra van der Vaart CMP | Compliance Officer | 65 | 01.02.19 |
Mark Schroeder COO | Chief Operating Officer | 63 | 01.05.07 |
Lance Berberian CTO | Chief Tech/Sci/R&D Officer | 61 | 01.02.14 |
Brian Caveney CTO | Chief Tech/Sci/R&D Officer | 50 | 25.09.17 |
Geraldine McDowell CTO | Chief Tech/Sci/R&D Officer | - | - |
Henry Dong PRN | Corporate Officer/Principal | - | - |
George Maha PRN | Corporate Officer/Principal | - | - |
Earle Collum PRN | Corporate Officer/Principal | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Adam Schechter CEO | Chief Executive Officer | 58 | 01.04.13 |
Peter Neupert BRD | Director/Board Member | 68 | 01.01.13 |
Kerrii Anderson BRD | Director/Board Member | 66 | 17.05.06 |
Jeffrey Davis BRD | Director/Board Member | 61 | 01.12.19 |
Paul Rothman BRD | Director/Board Member | 66 | 06.06.23 |
Garheng Kong BRD | Director/Board Member | 49 | 01.12.13 |
Richelle Parham BRD | Director/Board Member | 56 | 08.02.16 |
D. Gilliland BRD | Director/Board Member | 69 | 01.04.14 |
Kathryn Wengel BRD | Director/Board Member | 58 | 25.03.21 |
Kirsten Kliphouse BRD | Director/Board Member | 57 | 12.10.22 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 84 293 628 | 84 000 632 ( 99,65%) | 0 | 99,65% |
Unternehmenskontakt
Laboratory Corp. of America Holdings
358 South Main Street
27215-5837, Burlington
+336 229 1127
Konzerngesellschaften
Name | Kategorie und Branche |
---|---|
COVANCE INC. | Pharmaceuticals: Major |
Chiltern International Ltd. Chiltern International Ltd. Miscellaneous Commercial ServicesCommercial Services Chiltern International, Inc. provides clinical research services. It offers clinical development, medical and scientific affairs, data and analysis, pharmacovigilance and strategic regulatory services. The firm serves biotech, pharmaceuticals, biosimilars and biologics and medical device and diagnostics industries. The company was founded in 1982 and is headquartered in Slough, the United Kingdom. | Miscellaneous Commercial Services |
Labcorp Early Development Laboratories Ltd. Labcorp Early Development Laboratories Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Fortrea Holdings, Inc., Labcorp Early Development Laboratories Ltd. is a British company that provides early-stage and late-stage product development services. The company is based in Harrogate, UK. Labcorp Early Development Laboratories was founded in 1974. | Miscellaneous Commercial Services |
Dynacare-Gamma Laboratory Partnership Dynacare-Gamma Laboratory Partnership Medical/Nursing ServicesHealth Services Gamma-Dynacare Medical Laboratories Inc, Providing Information, Impacting Lives, Caring for People. By living this mission, Gamma-Dynacare Medical Laboratories will achieve its vision of becoming the trusted leader in transforming laboratory information and services into solutions that improve health, wellness and the Canadian health care system.Gamma-Dynacare is one of Canada's largest and most respected providers of laboratory services and solutions, with more than 50 years of experience serving Canadians. Each day, they support tens of thousands of patients, healthcare professionals and public and private sector clients with the efficient collection and transportation of specimens, accurate testing in their state-of-the-art laboratories and prompt reporting of results. | Medical/Nursing Services |
Labcorp Central Laboratory Services SARL Labcorp Central Laboratory Services SARL Miscellaneous Commercial ServicesCommercial Services Covance Central Laboratory Services SA provides diagnostic services. It also provides analytic services for the medical profession. The company was founded in 1992 and is headquartered in Meyrin-Geneva, Switzerland. | Miscellaneous Commercial Services |
Fortrea Development Ltd. Fortrea Development Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Fortrea Holdings, Inc., Fortrea Development Ltd. is a British company that provides clinical development services. The company is based in Maidenhead, UK. | Miscellaneous Commercial Services |
Fortrea Clinical Research Unit Ltd. Fortrea Clinical Research Unit Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Fortrea Holdings, Inc., Fortrea Clinical Research Unit Ltd. is a British clinical research company. The company is based in Leeds, UK. Founded in 1991, Fortrea Clinical Research Unit functions as a clinical research company. | Miscellaneous Commercial Services |
Fortrea UK Holdings Ltd. Fortrea UK Holdings Ltd. Financial ConglomeratesFinance Part of Fortrea Holdings, Inc., Fortrea UK Holdings Ltd. is an investment holding company. Fortrea UK Holdings Ltd. is based in Harrogate, UK. Founded in 1991. | Financial Conglomerates |
Labcorp International Holdings BV |
Sektor
Gesundheitspflege | ||||||
Gesundheitspflege Dienstleistungen | ||||||
Gesundheitspflege Dienstleistungen | ||||||
Gesundheitspflege Einrichtungen | ||||||
Einrichtungen und Dienste des Gesundheitswesens - Andere |
Umsatz nach Geschäftsbereich
Umsatz je Region
Ratings für Labcorp Holdings Inc.
Trading Rating
Investment Rating
ESG Refinitiv
Mehr Ratings
Analystenschätzungen
Verkaufen
Kaufen
Durchschnittl. Empfehlung
KAUFEN
Anzahl Analysten
17
Letzter Schlusskurs
210,6USD
Mittleres Kursziel
239,7USD
Abstand / Durchschnittliches Kursziel
+13,81%
Analystenschätzungen
Verlauf des Gewinns je Aktie
Entwicklung der Schätzungen
Quartalsgewinne - Abweichungsrate
Unternehmenstermine
Sektor Einrichtungen und Dienste des Gesundheitswesens - Andere
% 1. Jan. | Kap. | |
---|---|---|
HCA HEALTHCARE, INC. | +19,13% | 84,56Mrd. |
CVS HEALTH CORPORATION | -27,19% | 72,41Mrd. |
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY | +2,04% | 27,73Mrd. |
-1,00% | 17,11Mrd. | |
QUEST DIAGNOSTICS INCORPORATED | +5,05% | 16,03Mrd. |
NATERA, INC. | +71,18% | 13,07Mrd. |
FRESENIUS MEDICAL CARE AG | +6,11% | 12,91Mrd. |
TENET HEALTHCARE CORPORATION | +70,81% | 12,55Mrd. |
DAVITA INC. | +33,01% | 12,26Mrd. |
Einrichtungen und Dienste des Gesundheitswesens - Andere
- Börse
- Aktien
- 895308 Aktie
- L1CA34 Aktie
- Unternehmen Labcorp Holdings Inc.